| 2020 |
Towler OW, Shore EM, Kaplan FS. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva. Bone. January 2020;130:115116. |
4 |
0 |
| 2020 |
Kaplan FS, Al Mukaddam M, Stanley A, Towler OW, Shore EM. Fibrodysplasia ossificans progressiva (FOP): a disorder of osteochondrogenesis. Bone. November 2020;140:115539. |
1 |
1 |
| 2022 |
Lau YK, Peck SH, Arginteanu T, Wu M, Lin M, Shore EM, Klein PS, Casal ML, Smith LJ. Effects of lithium administration on vertebral bone disease in mucopolysaccharidosis I dogs. Bone. January 2022;154:116237. |
0 |
0 |
| 2016 |
Pignolo RJ, Bedford-Gay C, Liljesthröm M, Durbin-Johnson BP, Shore EM, Rocke DM, Kaplan FS. The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment. J Bone Miner Res. March 2016;31(3):650-656. |
11 |
1 |
| 2022 |
Wentworth KL, Lalonde RL, Groppe JC, Brewer N, Moody T, Hansberry S, Taylor KE, Shore EM, Kaplan FS, Pignolo RJ, Yelick PC, Hsiao EC. Functional testing of bone morphogenetic protein (BMP) pathway variants identified on whole-exome sequencing in a patient with delayed-onset fibrodysplasia ossificans progressiva (FOP) using ACVR1R206H-specific human cellular and zebrafish models. J Bone Miner Res. November 2022;37(11):2058-2076. |
1 |
1 |
| 2023 |
Allen RS, Jones WD, Hale M, Warder BN, Shore EM, Mullins MC. Reduced GS domain serine/threonine requirements of fibrodysplasia ossificans progressiva mutant Type I BMP receptor ACVR1 in the zebrafish. J Bone Miner Res. September 2023;38(9):1364-1385. |
0 |
0 |
| 2006 |
Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho T-J, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. May 2006;38(5):525-528. |
36 |
24 |